Union minister Ashwini Vaishnaw, MIB secretary Sanjay Jaju, YouTube India MD Gunjan Soni and others at the launch of AI skilling programme MIB starts AI training drive for 15,000 participants from the ...
Meta-owned Facebook launched a new monetisation programme for established creators on Wednesday, designed to offer them increased reach and guaranteed pay for three months on eligible reels to better ...
The Board of Directors of Gabriel Holding A/S has today resolved to repurchase the company’s own shares based on the authorization granted at the Annual General Meeting on 11 December 2025. The ...
YouTube is expanding its efforts to combat deepfakes and other AI-generated impersonations. On Tuesday, March 10, the video platform announced in a blog post that it is broadening a program designed ...
Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...
Social media companies are under pressure to crack down on so-called deepfake videos that use deceptive images of real people. By Natallie Rocha Reporting from San Francisco YouTube is adding a ...
(RTTNews) - Genmab A/S (GMAB) announced that it is initiating a share buy-back program and has entered into a non-discretionary instruction with Danske Bank. Under this share buy-back program, Genmab ...
Genmab has entered into a non-discretionary instruction with Danske Bank in relation to the share buy-back program. Danske Bank will make its own trading decisions and act independently of and without ...
A.P. Møller - Mærsk A/S (the "Company”) has decided to initiate a share buy-back program of up to DKK 6.3 billion (around USD 1 billion) to be executed over a period of 12 months. The first phase of ...
Glenveagh Properties plc ("Glenveagh" or the "Group") announces that it has entered arrangements today with Jefferies International Limited ("Jefferies") to repurchase ordinary shares of 0.001 each ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...